Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study-Reference-Cited by-同舟云学术

Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study

Published:2020-07-08 Issue:9 Volume:34 Page:2533-2535
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ector Geneviève I. C. G.^ORCID,Huijskens Elisabeth G. W.,Blijlevens Nicole M. A.,Westerweel Peter E.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0964-0.pdf

Reference3 articles.

1. Li W, Wang D, Guo J, Yuan G, Yang Z, Gale RP, et al. COVID-19 in persons with chronic myeloid leukaemia. Leukemia. 2020:1–6.

2. Ector GI, Westerweel PE, Hermens RP, Braspenning KA, Heeren BC, Vinck OM, et al. The development of a web-based, patient-centered intervention for patients with chronic myeloid leukemia (CMyLife): design thinking development approach. J Med Internet Res. 2020;22:e15895.

3. Epidemiologische situatie COVID-19 Nederland 03-06-2020. Bron: Rijksinstituut voor Volksgezondheid en Milieu (RIVM); 2020. https://www.rivm.nl/documenten/epidemiologische-situatie-covid-19-in-nederland-3-juni-2020.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey;Leukemia & Lymphoma;2023-11-15

2. Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era;Annals of Hematology;2023-08-14

3. Management of chronic myelogenous leukemia with COVID-19 and hepatitis B;Frontiers in Oncology;2023-08-03

4. Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial;BMC Health Services Research;2023-03-08

5. COVID-19 pneumonia concurrent with newly diagnosed chronic myelogenous leukemia;Blood Research;2022-03-31